Clinical Trials Directory

Trials / Sponsors / Wuhan YZY Biopharma Co., Ltd.

Wuhan YZY Biopharma Co., Ltd.

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Active Not RecruitingTreatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody
Malignant Ascites
Phase 32024-03-20
Active Not RecruitingA Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic C
Advanced Pancreatic Adenocarcinoma
Phase 1 / Phase 22023-02-08
RecruitingA Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC
Malignant Pleural Effusions, NSCLC Stage IV
Phase 1 / Phase 22022-09-30
CompletedTreat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody
Malignant Ascites
Phase 22021-11-24
CompletedA Trial of Y101D, a PD-L1/TGF-β Bispecific Antibody, in Patients With Metastatic or Locally Advanced Solid Tum
Metastatic or Locally Advanced Solid Tumors
Phase 12021-08-06
CompletedA Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Phase 12021-07-08
CompletedA Study of M701 (EpCAM and CD3) in Malignant Ascites
Malignant Ascites, Cancer
Phase 12018-09-30
CompletedA Study of M802 (HER2 and CD3) in HER2-Positive Advanced Solid Tumors
HER2-Positive Solid Tumors
Phase 12018-09-27